Novipharma is a Swiss registered company with headquarters in Nyon, Vaud. Novipharma is owned by the Portuguese pharmaceutical company BIAL since 2008.
Our goal is the management of the global supply chain for new medicines resulting from BIAL's R&D activities as well as to be the platform for pan-European and North-American growth of BIAL's sales.